Status of Bispecific Monoclonal Antibodies for Cancer Therapy

This publication has 56 references indexed in Scilit:

• Treatment of B-cell lymphomas with combination of bispecific antibodies and saporin
  The Lancet, 1995
• Development of a bispecific monoclonal antibody against a gallium-67 chelate and the human melanoma-associated antigen p97 for potential use in pretargeted immunoscintigraphy
  Cancer Immunology, Immunotherapy, 1993
• CD30‐antigen‐specific targeting and activation of T cells via murine bispecific monoclonal antibodies against CD3 and CD28: Potential use for the treatment of hodgkin's lymphoma
  International Journal of Cancer, 1993
• Tumor Rejection After Direct Costimulation of CD8 ⁺ T Cells by B7-Transfected Melanoma Cells
  Science, 1993
• Bispecific-monoclonal-antibody-directed lysis of ovarian carcinoma cells by activated human T lymphocytes
  Cancer Immunology, Immunotherapy, 1991
• Activation and expansion of tumour-infiltrating lymphocytes by anti-CD3 and anti-CD28 monoclonal antibodies
  Cancer Immunology, Immunotherapy, 1990
• Role of the CD28 receptor in T-cell activation
  Immunology Today, 1990
• Cytotoxicity mediated by human Fc receptors for IgG
  Immunology Today, 1989
• Structure and Function of Human and Murine Receptors for IgG
  Annual Review of Immunology, 1988
• Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer
  New England Journal of Medicine, 1985